Author Correction: ASS1 metabolically contributes to the nuclear and cytosolic p53-mediated DNA damage response

Affiliations

¹ Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
² Department of Medicine D, Beilinson Hospital, Petah Tikva, Israel.
³ Telethon Institute of Genetics and Medicine, Pozzuoli, Italy.
⁴ Department of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot, Israel.
⁵ Department of Molecular Neuroscience, Weizmann Institute of Science, Rehovot, Israel.
⁶ Department of Biochemistry and Molecular Biology, The Institute for Medical Research Israel-Canada, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
⁷ Department of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.
⁸ The De Botton Protein Profiling Institute of the Nancy and Stephen Grand Israel National Center for Personalized Medicine, Weizmann Institute of Science, Rehovot, Israel.
⁹ Cancer Data Science Lab, Center for Cancer Research, National Cancer Institute, National Institute of Health, Bethesda, MD, USA.
¹⁰ Department of Translational Medicine, Medical Genetics, University of Naples Federico II, Naples, Italy.
¹¹ Scuola Superiore Meridionale (SSM, School of Advanced Studies), Genomics and Experimental Medicine Program, University of Naples Federico II, Naples, Italy.
¹² Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel. ayelet.erez@weizmann.ac.il.

^# Contributed equally.

Published Erratum

Lisha Qiu Jin Lim et al. Nat Metab. 2024 Jul.

. 2024 Jul;6(7):1417.

doi: 10.1038/s42255-024-01090-z.

¹ Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
² Department of Medicine D, Beilinson Hospital, Petah Tikva, Israel.
³ Telethon Institute of Genetics and Medicine, Pozzuoli, Italy.
⁴ Department of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot, Israel.
⁵ Department of Molecular Neuroscience, Weizmann Institute of Science, Rehovot, Israel.
⁶ Department of Biochemistry and Molecular Biology, The Institute for Medical Research Israel-Canada, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
⁷ Department of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.
⁸ The De Botton Protein Profiling Institute of the Nancy and Stephen Grand Israel National Center for Personalized Medicine, Weizmann Institute of Science, Rehovot, Israel.
⁹ Cancer Data Science Lab, Center for Cancer Research, National Cancer Institute, National Institute of Health, Bethesda, MD, USA.
¹⁰ Department of Translational Medicine, Medical Genetics, University of Naples Federico II, Naples, Italy.
¹¹ Scuola Superiore Meridionale (SSM, School of Advanced Studies), Genomics and Experimental Medicine Program, University of Naples Federico II, Naples, Italy.
¹² Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel. ayelet.erez@weizmann.ac.il.

^# Contributed equally.

No abstract available

Erratum for

ASS1 metabolically contributes to the nuclear and cytosolic p53-mediated DNA damage response.
Lim LQJ, Adler L, Hajaj E, Soria LR, Perry RB, Darzi N, Brody R, Furth N, Lichtenstein M, Bab-Dinitz E, Porat Z, Melman T, Brandis A, Malitsky S, Itkin M, Aylon Y, Ben-Dor S, Orr I, Pri-Or A, Seger R, Shaul Y, Ruppin E, Oren M, Perez M, Meier J, Brunetti-Pierri N, Shema E, Ulitsky I, Erez A. Lim LQJ, et al. Nat Metab. 2024 Jul;6(7):1294-1309. doi: 10.1038/s42255-024-01060-5. Epub 2024 Jun 10. Nat Metab. 2024. PMID: 38858597 Free PMC article.